Moderna Inc. Stock Rallies 5.4%, Outperforms Peers
Dow Jones2026/09/11 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.
This was the stock's second consecutive day of gains.
Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.
Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 11, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Australian job market suddenly stalls! Unemployment rate hits a five-year high, traders move forward Reserve Bank rate cut bets to September next year
Australia's soaring unemployment rate has prompted traders to price in interest rate cuts.

Satoshi Nakamoto's dormant forum resurfaces: Who logged into the admin account in 2014?
RootData: HUMA will unlock tokens worth approximately $4.13 million in one week

